‹ Pipeline

Transposon’s discovery program includes a robust pipeline of innovative nucleoside reverse transcriptase inhibitors ready to be deployed in preclinical studies that explore indications with high unmet medical needs such as auto-immune, age-related, and rare neurodegenerative diseases, as well as, cancer.